FOOTHILL RANCH, CA--(Marketwire - 05/05/10) - Össur, a global leader in non-invasive orthopaedics, announced today that it has been awarded a sole source supplier contract with Mayo Clinic, a Novation Shareholder. As of March 1st, Össur initiated a 3-year agreement to supply functional knee bracing and supports, post-operative bracing, and other sports bracing products to Mayo Clinic-eligible facilities. The contract includes the new and improved Innovator DLX® post-op knee brace, which provides clinicians with the latest technology to treat patients following knee surgery.
The contract decision-making process was based on extensive Mayo Clinic driven criteria, including value, product line breadth, clinical acceptability, new product development, and service capabilities.
“We welcome the opportunity to provide Össur’s innovative products and excellent service to such a cutting-edge, quality-of-care-driven customer as Mayo Clinic,” said Mahesh Mansukhani, president of Össur Americas. “Together, we will better meet our customers’ growing needs for value and quality,” he added.
About Össur Össur (NASDAQ/OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapies. A recognized “Technology Pioneer,” Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. Website: www.ossur.com.
Contact Össur Americas: Mary Nash Director of Marketing Communications (949) 382-3844 mnash@ossur.com
